Exclusive copyright, patent, know how, process and technology cross-license to exploit, develop, research, manufacture, label, package, process, commercialize, promote, market, sell, distribute, import, export and sublicense the TAK-385 and TAK-448 products and chemical or oligopeptide compounds, to treat, prevent, cure or control symptoms of uterine fibroids, endometriosis or prostate cancer.